Sinemet CR, a controlled release carbidopa/levodopa preparation, was compared to conventional carbidopa/levodopa in a double blind, placebo-controlled trial. Comparable clinical benefits and adverse effects were noted with the two medications. However significantly less frequent dosing was necessary with Sinemet CR.
|Original language||English (US)|
|Number of pages||3|
|Journal||The Nebraska medical journal|
|State||Published - Jan 1991|
ASJC Scopus subject areas